Pfenex Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,204.00
45,722.00
110,121.00
81,501.00
57,864.00
56,420
Total Accounts Receivable
3,859.00
1,686.00
3,191.00
3,539.00
1,944.00
5,378
Inventories
26.00
23.00
24.00
-
-
-
Other Current Assets
3,765.00
5,334.00
1,694.00
1,878.00
1,705.00
1,851
Total Current Assets
12,854.00
52,765.00
115,030.00
86,918.00
61,513.00
63,649
Net Property, Plant & Equipment
2,329.00
2,310.00
3,179.00
5,246.00
7,397.00
7,671
Total Investments and Advances
4,029.00
3,955.00
-
-
-
-
Long-Term Note Receivable
95.00
-
-
-
-
-
Intangible Assets
12,470.00
11,940.00
11,409.00
10,878.00
10,348.00
9,825
Other Assets
36.00
53.00
121.00
80.00
133.00
133
Total Assets
31,813.00
71,023.00
131,694.00
103,122.00
79,391.00
81,278
ST Debt & Current Portion LT Debt
-
3,813.00
3,813.00
-
228.00
Accounts Payable
1,804.00
1,129.00
886.00
1,284.00
1,905.00
Income Tax Payable
-
-
1,676.00
-
-
Other Current Liabilities
4,206.00
2,834.00
9,867.00
15,928.00
16,334.00
Total Current Liabilities
6,010.00
7,776.00
16,242.00
17,212.00
18,467.00
Long-Term Debt
3,590.00
-
-
-
419.00
Deferred Taxes
3,481.00
3,281.00
1,955.00
-
-
Other Liabilities
3.00
92.00
44,271.00
5,765.00
2,742.00
Total Liabilities
13,084.00
11,149.00
60,513.00
22,977.00
21,628.00
Common Equity (Total)
94,451.00
59,874.00
71,181.00
80,145.00
57,763.00
Total Shareholders' Equity
18,729.00
59,874.00
71,181.00
80,145.00
57,763.00
Total Equity
18,729.00
59,874.00
71,181.00
80,145.00
57,763.00
Liabilities & Shareholders' Equity
31,813.00
71,023.00
131,694.00
103,122.00
79,391.00
Preferred Stock (Carrying Value)
113,180.00
-
-
-
-

About Pfenex

View Profile
Address
10790 Roselle Street
San Diego California 92121
United States
Employees -
Website http://www.pfenex.com
Updated 07/08/2019
Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.